SILENCE THERAPEUTICS PLC's ticker is SLN and the CUSIP is 82686Q101. A total of 26 filers reported holding SILENCE THERAPEUTICS PLC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,827,729 | +78.7% | 1,508,416 | 0.0% | 0.40% | +73.2% |
| Q2 2023 | $8,296,288 | -11.3% | 1,508,416 | 0.0% | 0.23% | -32.5% |
| Q1 2023 | $9,352,179 | -59.3% | 1,508,416 | 0.0% | 0.34% | -64.8% |
| Q4 2022 | $23,003,344 | +54.5% | 1,508,416 | 0.0% | 0.97% | +57.9% |
| Q3 2022 | $14,888,000 | +88.5% | 1,508,416 | +126.3% | 0.62% | +61.0% |
| Q2 2022 | $7,900,000 | -37.6% | 666,666 | 0.0% | 0.38% | -24.7% |
| Q1 2022 | $12,667,000 | -18.8% | 666,666 | 0.0% | 0.51% | -10.4% |
| Q4 2021 | $15,600,000 | +8.2% | 666,666 | 0.0% | 0.57% | +0.7% |
| Q3 2021 | $14,413,000 | -15.3% | 666,666 | 0.0% | 0.56% | -11.8% |
| Q2 2021 | $17,007,000 | +7.5% | 666,666 | 0.0% | 0.64% | +7.4% |
| Q1 2021 | $15,820,000 | – | 666,666 | – | 0.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 634,270 | $7,516,000 | 31.70% |
| Lombard Odier Asset Management (USA) Corp | 3,766,369 | $38,166,000 | 1.47% |
| GREAT POINT PARTNERS LLC | 401,449 | $4,757,000 | 1.14% |
| Frazier Life Sciences Management, L.P. | 881,173 | $10,442,000 | 0.98% |
| Deep Track Capital, LP | 951,580 | $11,276,000 | 0.74% |
| BVF INC/IL | 666,666 | $7,900,000 | 0.38% |
| Parkman Healthcare Partners LLC | 26,250 | $311,000 | 0.12% |
| CANTOR FITZGERALD, L. P. | 211,460 | $2,506,000 | 0.05% |
| AXA S.A. | 1,283,332 | $15,207,742 | 0.03% |
| WS MANAGEMENT LLLP | 25,000 | $296,000 | 0.02% |